0105 GMT - IHH Healthcare's near-term growth is expected to remain supported by continued expansion of its daycare business, with greater emphasis on quality and efficiency of care, CIMB Securities analyst Chun Sung Oong says in a note. Growth could also be driven by the phased reopening of Mount Elizabeth Hospital Orchard in Singapore and stronger operational synergies in India, he says. To manage near-term headwinds in Singapore's operations, IHH is optimizing resource utilization by directing lower-severity cases to Gleneagles Singapore and Parkway East Hospital, while the Mount Elizabeth hospitals focus on higher-intensity treatments, he notes. Oong raises IHH's 2026-2028 core net profit estimates by 1% each. CIMB maintains a buy rating on IHH and keeps its target price at 10.30 ringgit. Shares are unchanged at 8.98 ringgit.(yingxian.wong@wsj.com)
(END) Dow Jones Newswires
May 27, 2026 21:05 ET (01:05 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.